Eli Lilly is the maker of the blockbuster GLP-1 drug tirzepatide, approved as Mounjaro for type 2 diabetes and Zepbound for chronic weight management and obstructive sleep apnea
Cookie Details
However, because of its dual-action formula, some patients may achieve greater results with Tirzepatide
While Retatrutide reduces overall body mass, Tesamorelin ensures that visceral fat decreases faster than other tissue types
The decision to combine these agents must be individualized based on patient-specific factors, including medical history, current medications, cardiovascular health, and response to previous weight management interventions
All dosing decisions, including how close a patient may get to a Retatrutide 9mg dose, are made by a licensed provider on a case-by-case basis